Action Point Financial Planning’s Harmony Biosciences HRMY Stock Holding History

Action Point Financial Planning’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$328	Buy	+10	New	+$315	﹤0.01%	2675

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Action Point Financial Planning's HRMY Position: Q2 2026 in Review

Action Point Financial Planning opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 10 shares worth $328. The stake represents ﹤0.01% of the portfolio and ranks #2675 among its holdings.

324 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Action Point Financial Planning held 10 shares of Harmony Biosciences worth $328 as of Q2 2026.
Harmony Biosciences was a new Action Point Financial Planning position in Q2 2026.
Harmony Biosciences made up ﹤0.01% of Action Point Financial Planning's portfolio in Q2 2026, its #2675 holding.
324 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Action Point Financial Planning's 13F filing for Q2 2026, filed 14 Aug 2026.